vorinostat has been researched along with Kidney Diseases in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, Y | 1 |
| Chen, EY | 1 |
| Liu, R | 1 |
| Chuang, PY | 1 |
| Mallipattu, SK | 1 |
| Tan, CM | 1 |
| Clark, NR | 1 |
| Deng, Y | 1 |
| Klotman, PE | 1 |
| Ma'ayan, A | 1 |
| He, JC | 1 |
1 other study available for vorinostat and Kidney Diseases
| Article | Year |
|---|---|
Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cell Line, Tumor; Drug Synergism; D | 2013 |